Comparative trends in coronary heart disease subgroup hospitalisation rates in England and Australia

Background Population-based coronary heart disease (CHD) studies have focused on myocardial infarction (MI) with limited data on trends across the spectrum of CHD. We investigated trends in hospitalisation rates for acute and chronic CHD subgroups in England and Australia from 1996 to 2013. Methods CHD hospitalisations for individuals aged 35–84 years were identified from electronic hospital data from 1996 to 2013 for England and Australia and from the Oxford Region and Western Australia. CHD subgroups identified were acute coronary syndromes (ACS) (MI and unstable angina) and chronic CHD (stable angina and ‘other CHD’). We calculated age-standardised and age-specific rates and estimated annual changes (95% CI) from age-adjusted Poisson regression. Results From 1996 to 2013, there were 4.9 million CHD hospitalisations in England and 2.6 million in Australia (67% men). From 1996 to 2003, there was between-country variation in the direction of trends in ACS and chronic CHD hospitalisation rates (p<0.001). During 2004–2013, reductions in ACS hospitalisation rates were greater than for chronic CHD hospitalisation rates in both countries, with the largest subgroup declines in unstable angina (England: men: −7.1 %/year, 95% CI −7.2 to –7.0; women: −7.5 %/year, 95% CI −7.7 to –7.3; Australia: men: −8.5 %/year, 95% CI −8.6 to –8.4; women: −8.6 %/year, 95% CI −8.8 to –8.4). Other CHD rates increased in individuals aged 75–84 years in both countries. Chronic CHD comprised half of all CHD admissions, with the majority involving angiography or percutaneous coronary intervention. Conclusions Since 2004, rates of all CHD subgroups have fallen, with greater declines in acute than chronic presentations. The slower declines and high proportion of chronic CHD admissions undergoing coronary procedures requires greater focus.

[1]  R. Baggott DISEASE , 1947, Social Policy & Administration.

[2]  G. Hankey,et al.  Trends in age- and sex-specific prevalence and incidence of cardiovascular disease in Western Australia , 2018, European journal of preventive cardiology.

[3]  G. Sulo,et al.  Trends in incident acute myocardial infarction in Norway: An updated analysis to 2014 using national data from the CVDNOR project , 2018, European journal of preventive cardiology.

[4]  G. Lemesle,et al.  Elective Coronary Revascularization Procedures in Patients With Stable Coronary Artery Disease: Incidence, Determinants, and Outcome (From the CORONOR Study). , 2018, JACC. Cardiovascular interventions.

[5]  M. Goldacre,et al.  Identification of myocardial infarction type from electronic hospital data in England and Australia: a comparative data linkage study , 2017, BMJ Open.

[6]  J. Beilby,et al.  Exploring the effects of transfers and readmissions on trends in population counts of hospital admissions for coronary heart disease: a Western Australian data linkage study , 2017, BMJ Open.

[7]  H. White,et al.  First and recurrent ischaemic heart disease events continue to decline in New Zealand, 2005–2015 , 2017, Heart.

[8]  P. Collinson,et al.  How Well Do Laboratories Adhere to Recommended Clinical Guidelines for the Management of Myocardial Infarction: The CARdiac MArker Guidelines Uptake in Europe Study (CARMAGUE). , 2016, Clinical chemistry.

[9]  H. Buchan,et al.  Variation in coronary angiography rates in Australia: correlations with socio‐demographic, health service and disease burden indices , 2016, The Medical journal of Australia.

[10]  L. Tavazzi,et al.  EURObservational Research Programme: the Chronic Ischaemic Cardiovascular Disease Registry: Pilot phase (CICD-PILOT) , 2016 .

[11]  M. Bots,et al.  Shifts in the age distribution and from acute to chronic coronary heart disease hospitalizations , 2016, European journal of preventive cardiology.

[12]  Bernadette A. Thomas,et al.  Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.

[13]  U. Keil,et al.  German nationwide data on current trends and management of acute myocardial infarction: discrepancies between trials and real-life. , 2014, European heart journal.

[14]  Ronan A Lyons,et al.  UK health performance: findings of the Global Burden of Disease Study 2010 , 2013, BDJ.

[15]  S. Capewell,et al.  Recent UK trends in the unequal burden of coronary heart disease , 2012, Heart.

[16]  A. Folsom,et al.  Twenty-Two–Year Trends in Incidence of Myocardial Infarction, Coronary Heart Disease Mortality, and Case Fatality in 4 US Communities, 1987–2008 , 2012, Circulation.

[17]  M. Goldacre,et al.  Determinants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: linked national database study , 2012, BMJ : British Medical Journal.

[18]  Graeme Miller,et al.  A decade of Australian general practice activity 2002–03 to 2011–12 , 2012 .

[19]  P. Austin,et al.  Secular trends in acute coronary syndrome hospitalization from 1994 to 2005. , 2010, The Canadian journal of cardiology.

[20]  M. Hobbs,et al.  Impact of new biomarkers of myocardial damage on trends in myocardial infarction hospital admission rates from population-based administrative data. , 2008, American journal of epidemiology.

[21]  Simon Capewell,et al.  Explaining the Decline in Coronary Heart Disease Mortality in England and Wales Between 1981 and 2000 , 2004, Circulation.

[22]  H. Tunstall-Pedoe,et al.  Contribution of trends in survival and coronar y-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations , 1999, The Lancet.